What does Bone Biologics Corporation do?
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company…
What is Bone Biologics Corporation's P/E and P/B ratio?
Bone Biologics Corporation has a P/E ratio of -0.3 and a P/B ratio of 0.28.
What is Bone Biologics Corporation's debt-to-equity ratio?
Bone Biologics Corporation has a debt-to-equity ratio of 0.00.
How much does Bone Biologics Corporation owe compared with what it owns?
Bone Biologics Corporation owes $0.12 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Bone Biologics Corporation's Positivity rank?
Bone Biologics Corporation is ranked #2,710 of 6,774 companies globally and #945 of 4,000 in United States on PositoAI, with a Positivity Score of 21,210.
Does Bone Biologics Corporation have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Yes. Bone Biologics Corporation has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 16 Sep 2026). It has no yellow flags.
Where can I read the latest news about Bone Biologics Corporation?
Recent headlines about Bone Biologics Corporation from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Bone Biologics Corporation have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Bone Biologics Corporation's current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.